Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of PF-06260414 Solid Dose vs. Nanosuspension in Healthy Subjects
NCT02393807Phase 1Withdrawn
- Sponsor
- Pfizer
- Start
- Jun 2015
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of PF-06260414 in pain, sponsored by Pfizer. Planned start Jun 2015; status: withdrawn.
02
Drugs
PF-06260414
03
Conditions
pain
Beyond the preview
Go deeper on NCT02393807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393807.